Replies to post #22484 on BioSante Pharmaceuticals, Inc. (BPAX)

[porgyrusty]

Its trading at .2566 R/S pricing, its off the 52 week high by 90.35%, those are some shocking numbers.

[homeslice10]

I misread that 2nd company info too, it could well be an Abvie or a BMY. its 30% stock position of them based upon OUR market cap as of time of the merge. So basically we're getting ripped off badly imo because we're trading at about 2-5% what we're really worth in trade value imo.